|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,419.19 USD | -0.09% |
|
-2.12% | +6.72% |
| 20/01 | Jefferies Adjusts Price Target on TransDigm Group to $1,635 From $1,525, Maintains Buy Rating | MT |
| 17/01 | Transdigm Group Insider Sold Shares Worth $10,726,454, According to a Recent SEC Filing | MT |
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.89 | 7.4 | 9.66 | 9.87 | 10.82 | |||||
Return on Total Capital | 6.53 | 8.24 | 10.8 | 12.32 | 13.43 | |||||
Return On Equity % | -19.8 | -25.94 | -45.23 | -41.52 | -25.99 | |||||
Return on Common Equity | -17.62 | -23.29 | -43.77 | -35.8 | -23.36 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 53.13 | 57.21 | 58.34 | 59.11 | 60.25 | |||||
SG&A Margin | 13.26 | 13.91 | 11.53 | 11.78 | 10.43 | |||||
EBITDA Margin % | 42.29 | 45.46 | 48.78 | 49.23 | 51.7 | |||||
EBITA Margin % | 39.89 | 43.32 | 46.82 | 47.36 | 49.86 | |||||
EBIT Margin % | 37.02 | 40.8 | 44.71 | 45.3 | 47.55 | |||||
Income From Continuing Operations Margin % | 14.19 | 15.95 | 19.73 | 21.6 | 23.49 | |||||
Net Income Margin % | 14.17 | 15.95 | 19.71 | 21.59 | 23.49 | |||||
Net Avail. For Common Margin % | 12.65 | 14.35 | 19.13 | 18.65 | 21.13 | |||||
Normalized Net Income Margin | 9.36 | 13.09 | 16.94 | 18.32 | 18.85 | |||||
Levered Free Cash Flow Margin | 15.9 | 15.53 | 15.33 | 74.19 | -33.09 | |||||
Unlevered Free Cash Flow Margin | 28.99 | 27.29 | 25.76 | 83.81 | -22.39 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.25 | 0.29 | 0.35 | 0.35 | 0.36 | |||||
Fixed Assets Turnover | 5.58 | 6.18 | 5.96 | 5.54 | 5.53 | |||||
Receivables Turnover (Average Receivables) | 5.93 | 5.58 | 5.25 | 5.17 | 4.98 | |||||
Inventory Turnover (Average Inventory) | 1.82 | 1.85 | 1.86 | 1.86 | 1.77 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 4.23 | 3.96 | 4.27 | 1.58 | 3.21 | |||||
Quick Ratio | 3.4 | 2.96 | 3.16 | 1.26 | 2.16 | |||||
Operating Cash Flow to Current Liabilities | 0.55 | 0.66 | 0.87 | 0.32 | 0.93 | |||||
Days Sales Outstanding (Average Receivables) | 61.51 | 65.45 | 69.48 | 70.8 | 73.32 | |||||
Days Outstanding Inventory (Average Inventory) | 200.27 | 197.74 | 196.14 | 196.81 | 206.47 | |||||
Average Days Payable Outstanding | 37.76 | 37.39 | 35.21 | 32.77 | 33.82 | |||||
Cash Conversion Cycle (Average Days) | 224.02 | 225.8 | 230.41 | 234.84 | 245.97 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | -700.24 | -527.99 | -1T | -397.1 | -310.82 | |||||
Total Debt / Total Capital | 116.66 | 123.37 | 111.06 | 133.66 | 147.43 | |||||
LT Debt/Equity | -674.6 | -516.2 | -981.9 | -387.51 | -301.9 | |||||
Long-Term Debt / Total Capital | 112.39 | 120.61 | 108.62 | 130.43 | 143.2 | |||||
Total Liabilities / Total Assets | 115.07 | 120.8 | 109.9 | 124.56 | 142.25 | |||||
EBIT / Interest Expense | 1.68 | 2.06 | 2.53 | 2.8 | 2.67 | |||||
EBITDA / Interest Expense | 1.94 | 2.32 | 2.78 | 3.06 | 2.92 | |||||
(EBITDA - Capex) / Interest Expense | 1.84 | 2.21 | 2.66 | 2.93 | 2.78 | |||||
Total Debt / EBITDA | 9.9 | 7.98 | 6.14 | 6.35 | 6.56 | |||||
Net Debt / EBITDA | 7.58 | 6.72 | 5.04 | 4.74 | 5.94 | |||||
Total Debt / (EBITDA - Capex) | 10.43 | 8.38 | 6.42 | 6.63 | 6.89 | |||||
Net Debt / (EBITDA - Capex) | 7.98 | 7.06 | 5.26 | 4.95 | 6.25 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -5.98 | 13.15 | 21.29 | 20.58 | 11.22 | |||||
Gross Profit, 1 Yr. Growth % | -5.38 | 21.71 | 23.98 | 22.09 | 13.38 | |||||
EBITDA, 1 Yr. Growth % | -4.43 | 21.4 | 30.52 | 21.97 | 16.78 | |||||
EBITA, 1 Yr. Growth % | -4.73 | 22.63 | 31.47 | 22.24 | 17.07 | |||||
EBIT, 1 Yr. Growth % | -3.48 | 24.44 | 33.33 | 22.47 | 16.7 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 4.29 | 27.17 | 50 | 32.02 | 20.93 | |||||
Net Income, 1 Yr. Growth % | -2.72 | 27.35 | 49.88 | 32.05 | 21 | |||||
Normalized Net Income, 1 Yr. Growth % | -18.12 | 57.45 | 57.86 | 29.63 | 14.46 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 27.53 | 28.78 | 64.57 | 16.32 | 25.13 | |||||
Accounts Receivable, 1 Yr. Growth % | 13.89 | 26.13 | 30.85 | 16.19 | 14.9 | |||||
Inventory, 1 Yr. Growth % | -7.64 | 12.4 | 21.32 | 16.09 | 11.67 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 1.05 | 3.24 | 47.87 | 17.44 | 6.13 | |||||
Total Assets, 1 Yr. Growth % | 5 | -6.25 | 10.29 | 28.12 | -10.46 | |||||
Tangible Book Value, 1 Yr. Growth % | -1.35 | 6.23 | -9.53 | 46.91 | 17.85 | |||||
Common Equity, 1 Yr. Growth % | -26.59 | 29.39 | -47.42 | 217.04 | 53.99 | |||||
Cash From Operations, 1 Yr. Growth % | -24.73 | 3.83 | 45.04 | 48.73 | -0.34 | |||||
Capital Expenditures, 1 Yr. Growth % | 0 | 13.33 | 16.81 | 18.7 | 34.55 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -57.22 | 8.81 | 28.03 | 486.03 | -149.6 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -41.9 | 5.62 | 18.85 | 293.36 | -129.72 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -4.15 | 3.14 | 17.15 | 20.93 | 15.8 | |||||
Gross Profit, 2 Yr. CAGR % | -4.74 | 8.32 | 23.65 | 23.06 | 17.68 | |||||
EBITDA, 2 Yr. CAGR % | -2.99 | 9.83 | 28.08 | 25.75 | 19.62 | |||||
EBITA, 2 Yr. CAGR % | -3.73 | 10.34 | 29.34 | 26.33 | 19.91 | |||||
EBIT, 2 Yr. CAGR % | -4.07 | 12.09 | 31.4 | 27.32 | 19.86 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -10.01 | 15.16 | 38.11 | 40.73 | 26.36 | |||||
Net Income, 2 Yr. CAGR % | -12.59 | 11.31 | 38.16 | 40.68 | 26.41 | |||||
Normalized Net Income, 2 Yr. CAGR % | -17.78 | 21.82 | 64.75 | 45.63 | 22.67 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -10.34 | 28.15 | 45.58 | 38.36 | 20.64 | |||||
Accounts Receivable, 2 Yr. CAGR % | -12.01 | 19.85 | 28.47 | 23.3 | 15.54 | |||||
Inventory, 2 Yr. CAGR % | -1.97 | 1.89 | 16.78 | 18.68 | 13.86 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 6.83 | 2.14 | 23.56 | 31.78 | 11.64 | |||||
Total Assets, 2 Yr. CAGR % | 9.01 | -0.79 | 1.68 | 18.87 | 7.11 | |||||
Tangible Book Value, 2 Yr. CAGR % | 2.99 | 2.37 | -1.97 | 15.29 | 31.58 | |||||
Common Equity, 2 Yr. CAGR % | 0.38 | -2.54 | -17.51 | 29.12 | 120.95 | |||||
Cash From Operations, 2 Yr. CAGR % | -5.16 | -11.6 | 22.72 | 46.87 | 21.74 | |||||
Capital Expenditures, 2 Yr. CAGR % | 1.46 | 6.46 | 15.06 | 17.75 | 26.38 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 49.79 | -30.32 | 29.96 | 210.4 | 71.34 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 187.09 | -20.53 | 17.63 | 130.73 | 8.44 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 7.98 | 1.3 | 8.87 | 18.28 | 17.61 | |||||
Gross Profit, 3 Yr. CAGR % | 5.29 | 3.41 | 13.22 | 23.15 | 19.74 | |||||
EBITDA, 3 Yr. CAGR % | 4.25 | 4.61 | 16.22 | 25.92 | 22.7 | |||||
EBITA, 3 Yr. CAGR % | 3.35 | 4.43 | 16.86 | 26.83 | 23.18 | |||||
EBIT, 3 Yr. CAGR % | 2.24 | 4.7 | 18.64 | 28.25 | 23.69 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -10.88 | 0.98 | 25.77 | 36.05 | 33.79 | |||||
Net Income, 3 Yr. CAGR % | -10.77 | -0.91 | 22.91 | 36.09 | 33.79 | |||||
Normalized Net Income, 3 Yr. CAGR % | -10.41 | 2.29 | 32.54 | 52.41 | 34.4 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -13.92 | 1.16 | 39.3 | 35.09 | 33.8 | |||||
Accounts Receivable, 3 Yr. CAGR % | 6.42 | -0.79 | 23.41 | 24.24 | 20.43 | |||||
Inventory, 3 Yr. CAGR % | 13.74 | 2.61 | 8 | 16.55 | 16.29 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 30.55 | 5.62 | 15.55 | 21.48 | 22.61 | |||||
Total Assets, 3 Yr. CAGR % | 16.56 | 3.66 | 2.78 | 9.83 | 8.16 | |||||
Tangible Book Value, 3 Yr. CAGR % | 13.28 | 4.06 | -1.76 | 12.19 | 16.13 | |||||
Common Equity, 3 Yr. CAGR % | 17.26 | 9.24 | -20.66 | 29.21 | 36.93 | |||||
Cash From Operations, 3 Yr. CAGR % | -3.69 | -2.25 | 4.27 | 30.84 | 29.06 | |||||
Capital Expenditures, 3 Yr. CAGR % | 12.88 | 5.27 | 9.8 | 16.26 | 23.1 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 2.22 | 35.33 | -16.53 | 114.39 | 68.45 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 7.91 | 106.28 | -10.25 | 75.76 | 16.53 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 8.63 | 9.15 | 11.56 | 8.74 | 11.59 | |||||
Gross Profit, 5 Yr. CAGR % | 7.69 | 9.15 | 11.96 | 10.81 | 14.99 | |||||
EBITDA, 5 Yr. CAGR % | 7 | 8.49 | 12.39 | 12.64 | 17.42 | |||||
EBITA, 5 Yr. CAGR % | 6.41 | 8.13 | 12.2 | 12.73 | 17.91 | |||||
EBIT, 5 Yr. CAGR % | 6.03 | 8.08 | 12.11 | 13.26 | 18.95 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 3.04 | 6.62 | 6.19 | 15.32 | 26 | |||||
Net Income, 5 Yr. CAGR % | 3.01 | 7.73 | 6.29 | 14.01 | 24.3 | |||||
Normalized Net Income, 5 Yr. CAGR % | -3.12 | 4.84 | 12.3 | 16.97 | 28.3 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 0.01 | 9.63 | 6.21 | 14.66 | 31.51 | |||||
Accounts Receivable, 5 Yr. CAGR % | 8.36 | 11.29 | 14.75 | 8.23 | 20.2 | |||||
Inventory, 5 Yr. CAGR % | 10.36 | 12.76 | 14.95 | 8.76 | 10.3 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 22.71 | 22.38 | 27.71 | 15.4 | 13.97 | |||||
Total Assets, 5 Yr. CAGR % | 12.48 | 12.66 | 10.36 | 9.5 | 4.49 | |||||
Tangible Book Value, 5 Yr. CAGR % | 12.01 | 7.8 | 6.92 | 8.41 | 10.42 | |||||
Common Equity, 5 Yr. CAGR % | 34.95 | 5.04 | 1.87 | 16.8 | 19.52 | |||||
Cash From Operations, 5 Yr. CAGR % | 5.97 | 3.75 | 6.11 | 15.04 | 10.94 | |||||
Capital Expenditures, 5 Yr. CAGR % | 19.01 | 10.88 | 13.75 | 10.1 | 16.15 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 9.78 | 8.16 | 7.16 | 76.89 | 10.98 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 12.71 | 9.88 | 8.91 | 108.53 | -3.36 |
- Stock Market
- Equities
- TDG Stock
- Financials TransDigm Group Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















